FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of pelvic Organ Prolapse and Stress Urinary Incontinence

//FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of pelvic Organ Prolapse and Stress Urinary Incontinence

FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of pelvic Organ Prolapse and Stress Urinary Incontinence

FDA Public Health Notification: October 20, 2008.

Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of pelvic Organ Prolapse and Stress Urinary Incontinence

This was the initial warning that said complications associated with transvaginal placement of surgical mesh are rare. That was corrected by July 2011.

This notification was at least in part, encouraged by the patient advocacy group, Truth in Medicine.

By | 2011-08-02T13:36:20+00:00 August 2nd, 2011|FDA News|1 Comment

About the Author:

I’m National News Editor, Jane Akre and I began Mesh Medical Device News Desk aka Mesh News Desk (MND) in the summer of 2011 just after the Food and Drug Administration issued an explicit warning to the public that complications associated with surgical mesh used for prolapse repair (POP) and incontinence (SUI) are NOT rare! That was the starting point for the litigation you see today and thousands of lawsuits have been filed by women whose lives have been altered, some permanently, by the use of this petroleum-based product.

Leave A Comment